Assessing the effectiveness of IMOD in Oral Lichen Planus

Phase 3

• Conditions: Oral Lichen Planus.; Lichen planus

• Registration Number: IRCT138801191559N2
• Lead Sponsor: Pars Roos Pharmaceutical Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Inclusion Criteria: Presence of oral lesions of oral Lichen Planus, Clinical diagnosis of oral lesions: i.e. bilateral or symmetrical reticular lesions with or without atrophic erosive or bolus lesions, Presence of microscopic diagnostic criteria of Lichen Planus: i.e. increase in keratinisation with increase in thickness of granular cell, hydropic degeneration of basal layer, sub-epithelial infiltration of T lymphocytes, no dysplasia), Age 18 - 64
Exclusion criteria: Presence of dysplasia in histopathological view, Presence of lesion close to the amalgam filling, Presence of significant systematic disorder, History of local or systematic therapy during a month prior to the study, Pregnancy or intention of becoming pregnant during the study period (6 months), Breastfeeding, Inability to give informed consent according to the agreed process, Any drug hypersensitivity, Receiving radiotherapy, chemotherapy or any immunosuppressive drug

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified